Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Radiation for CNS Melanoma
NCT00068666Phase 2Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in melanoma, sponsored by Cancer and Leukemia Group B. Started Jan 2004; status: terminated.
02
Drugs
temozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00068666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068666.